Table 3.
Predicting adherence longitudinally at baseline and 32 weeks of pregnancy, and 6 weeks, 6, and 12 months post-partum.
| Maternal 100% 4-day | ||
|---|---|---|
| ACTG Adherence | ||
| Variable | AOR [95% CI] | |
| Fixed effects | ||
| Condition | 0.588 [0.212, 1.627] | |
| Phase | 1.303 [0.841, 2.020] | |
| Intervention ×Phase | 0.853 [0.455, 1.598] | |
| Controls (at baseline) | ||
| Age | 0.976 [0.948, 1.004] | |
| Monthly income | 1.142 [0.825, 1.579] | |
| Partner HIV positive | 0.546 [0.331, 0.899]* | |
| Time since ART initiation | 0.997 [0.988, 1.005] | |
| Time since HIV diagnosis | 0.997 [0.992, 1.003] | |
| Family planning knowledge | 0.901 [0.811, 1.003] | |
| Depression | 0.925 [0.901, 0.949]*** | |
| Male involvement | 1.041 [0.984, 1.100] | |
| Random Effectsa | B (SE) | 95% CI |
| Intercept (baseline) | −0.025 (0.038) | −0.099, 0.049 |
| Adherence | 0.002 (0.001) | 0.001, 0.004 |
| Model fit | ||
| −2LL (Deviance) | 7307.778 | |
| Numbers of parameters | 27 | |
| AIC/BIC | 7372.109/7503.464 | |
| ICC (without covariates) | 0.000 |